Although the CRO sector has been around for decades, it is now evolving faster than ever as competition among organizations grows as the medication research process becomes increasingly complex. Today, CROs have evolved into a vital component of the biotech, pharmaceutical, and medical device industries; partnering with a competent CRO can save time spent on documentation, approvals, trials, and resource management, among other things. Furthermore, the Indian government is taking proactive steps to accelerate the expansion of the pharmaceutical and healthcare industries by inviting large firms to undertake clinical trials in the country. This significantly draws international investment for the country's economic and scientific development.
Speaking of which, the Indian pharmaceutical space plays a pivotal role in the global pharmaceutical picture. The country ranks third in terms of production and volume, and 14th in terms of value. An increase in global demand for cost-effective and dependable formulations has presented the Indian pharmaceutical domain with a once-in-a-lifetime opportunity to transit from the ‘Pharmacy of the World’ to a ‘Global Research Hub.’ Having said that, a pressing point for pharmaceutical companies has been the lack of broad-spectrum platforms in terms of different service specializations, housed under one roof in a tightly-knit consortium, which costs a significant amount of time and money.
Veena Kanwar, Managing Director
As one of the fastest-growing entities in the pharmaceutical industry, Indivirtus has become a reckoning name in the market that has been offering all-encompassing drug development solutions for varied industry verticals under one roof. Indivirtus has carved a niche for itself in offering a comprehensive range of services which includes Calculation of HBEL (PDE/ADE and OEL values for cleaning and validation), Mutagenic Assessment & qualification of Impurities, Medical Writing, Pharmacovigilance, Risk Management Plan, Clinical Trials, Regulatory Services, GxP Services, Plant approvals and vendor audits, Qualification & Validation, Training, Computer System Validation, Instrument Calibration, Pre-Clinical Studies, Formulation Development, Technology Transfer, Export of APIs and Finished Formulations with many more in the pipeline.
In a very short span of four years, Indivirtus is all set to launch analytical and bioequivalence centers thus completely taking over the market and becoming an inevitable option for the customers. Today, Indivirtus has become a pioneer in toxicological risk assessment and has prepared more than 6500 PDE reports to date, without any regulatory failure. Indivirtus has served more than 40 international and 280 domestic companies. In such a short span of time, Indivirtus has grown from a single entity to a group of four companies namely Indivirtus Healthcare Services, Indivirtus Strategic Solutions, Indivirtus-AB7 Scribing and RCM, and Indivirtus Solutions. Apart from India, Indivirtus has business offices in the USA, UK, Canada, UAE, and Egypt.
“At Indivirtus, our motto is to provide a perfect blend of Quality and Economy. Since all the services are provided internally, there is constant coordination and communication between all the teams. We are currently one of the top 10 CROs in India. Indivirtus has a proven track record in offering real-time cost-effective solutions to the healthcare industry. Being across the pharmaceutical front, Indivirtus has been successfully aiding healthcare professionals and industry to maximize their efficiencies in their core competencies and also support in the expansion of their business”, says Dr. Upendra K. Jain, Founder and CEO, Indivirtus.
Indivirtus strives to be a one-stop solution provider for every service in relation to the drug’s lifecycle and beyond. To fulfill its motto, Indivirtus offers an all-encompassing solution that covers
toxicological services, pharmacovigilance, clinical research, regulatory affairs, computer system validation & equipment calibration, technology transfer, audits, training, formulation development, and exports.
Ensuring Best-in-class Client Experience
To stand out from the crowd, Indivirtus gives the utmost value to provide top-notch quality and excellent customer service. Its persistence and continuous upgradation coupled with a team of skilled and well-informed professionals has helped Indivirtus to stay ahead of the curve and drive needed innovation. Indivirtus operations are focused on keeping clients at the helm to ensure best-in-class customer service.
A fair share of investment has been made to build an ecosystem of competent professionals with robust infrastructure in place and protocols. When analyzing ROI, the best quantitative measures to consider are renewals & repurchase rates, product/service engagement rates, and overall customer satisfaction. Most of Indivirtus' customers are repeat customers as Indivirtus always goes above and beyond to conduct surveys and check their quantitative and qualitative feedback.
“We find our edge when it comes to facilitating our customers with quality outcomes and financial prudence/ cost-avoidance. We provide good quality service at an economical price since all pharma companies are fighting with thin margins and hence it is sometimes difficult for them to afford the services of a CRO. In order to tackle this situation, Indivirtus has come up with an excellent idea of a 'perfect blend of quality and economy'.
All services provided by Indivirtus are far more economical compared to other CROs without compromising on quality”, asserts Dr. Upendra. Indivirtus believes in hand-holding its clients right through the engagement process with transparent and ethical service deliverability. Clients are always in the loop and are informed about all the developments in real time. Every client is handled by a subject matter expert (SME) who delves in deep to deliver upon the client’s demand. Indivirtus values its relations with the client and hence supports the clients in any kind of query-solving besides the paid services they have opted for.
“One of our customers, a multinational chain in various locations, was struggling with managing their cleaning validation protocol. With a growing number of customers, they found it challenging to provide quick and effective solutions, resulting in regulatory queries and low customer satisfaction rates. The service of health-based exposure limits redirected them to the appropriate designing of cleaning validation protocol. This helped in reducing the burden by avoiding the usage of stringent values derived from an inappropriate method resulting in customer satisfaction levels”, explains Dr. Upendra about one of the many notable Indivirtus’ client engagements.
The aforementioned clients also gained valuable insights into their customer behavior and trends, which enabled them to identify potential areas for improvement and optimize their processes accordingly. By leveraging Indivirtus’ services, the chain was able to enhance its customer service experience and increase customer loyalty and retention. Overall, the solution offered helped the customer streamline their customer service operations, reduce costs, and improve customer satisfaction, leading to enhanced business performance.
Indivirtus' focus is to provide onestop solutions across all spectrums of services required by any pharmaceutical company without compromising on quality & economy
A Competent Team With Future Sightedness
Indivirtus is backed by a skilled and highly experienced team of seasoned professionals from different backgrounds including management, accounts & finance, human resource, information technology, computer applications, business development, equipment calibration, sales & marketing, and more. All the professionals carry years of industry experience spanning academic, research, medical writing, regulatory filing, documentation, pharmacovigilance, quality assurance, and toxicological studies. The entire team takes very active participation in exhibitions, conferences, seminars, aggressive business development strategies, punctual & disciplined management, and above all honesty and sheer hard work are the traits that make Indivirtus stand ahead of other players in this field.
An Evangelizing Roadmap
Indivirtus is in a constant endeavor to achieve perfection and for this objective, routine trainings are provided to keep the team updated with the latest regulatory revisions and new developments in the market. The company is also nurturing talented individuals by giving them opportunities by hiring them and making them work on innovative projects. All operations in Indivirtus are performed in-line with the standard operating procedures and periodical audits, internal and customer audits, help in maintaining the quality and compliance with the regulatory guidelines. Fairtrade policies amalgamated with a perfect blend of quality and economy is something that always keeps Indivirtus ahead of the curve.
Going forward, Indivirtus plans to start a clinical facility for Bioequivalence (BE) studies on its own. It is further looking to partner with more formulation manufacturers for technology transfers (TT) to new sites which will generate business not only for TT but also for pivotal BE studies. And as stated earlier, Indivirtus is also looking forward to starting its own lab for analytical/bioanalytical services and is keen to start business offices in Europe, Australia & South Africa. “Our vision is to be among the top five globally competent, medical and health economics companies, capable of providing timely and accurate solutions, with the highest integrity, while also providing a challenging and growthoriented environment to our team of experts, having a great sense of pride and achievement”, concludes Dr. Upendra.
